Methodology for Quantitative Rapid Multi-Tracer PET Tumor Characterizations
暂无分享,去创建一个
[1] K. Någren,et al. Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: a PET study. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[2] J. Hoffman,et al. Comparison of 18F-Fluorodeoxyglucose and 18F-Fluorothymidine PET in Differentiating Radiation Necrosis From Recurrent Glioma , 2012, Clinical nuclear medicine.
[3] H. Minn,et al. Pharmacokinetics of [18F]FETNIM: a potential marker for PET. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] Nobuyuki Oyama,et al. 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[5] David J. Yang,et al. Development of F-18-labeled fluoroerythronitroimidazole as a PET agent for imaging tumor hypoxia. , 1995, Radiology.
[6] P. Vaupel,et al. Blood supply, oxygenation status and metabolic micromilieu of breast cancers: characterization and therapeutic relevance. , 2000, International journal of oncology.
[7] K Kubota,et al. From tumor biology to clinical PET: A review of positron emission tomography (PET) in oncology , 2001, Annals of nuclear medicine.
[8] E. Nitzsche,et al. Combined FDG and [F-18]fluoride whole-body PET: a feasible two-in-one approach to cancer imaging? , 1998, Radiology.
[9] K. Ishiwata,et al. Tracer feasibility for monitoring tumor radiotherapy: a quadruple tracer study with fluorine-18-fluorodeoxyglucose or fluorine-18-fluorodeoxyuridine, L-[methyl-14C]methionine, [6-3H]thymidine, and gallium-67. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[10] I. Lemahieu,et al. Noise properties of simultaneous dual tracer PET imaging , 2005, IEEE Nuclear Science Symposium Conference Record, 2005.
[11] Kenneth A Krohn,et al. Imaging hypoxia and angiogenesis in tumors. , 2005, Radiologic clinics of North America.
[12] C Burger,et al. Quantitative PET studies in pretreated melanoma patients: a comparison of 6-[18F]fluoro-L-dopa with 18F-FDG and (15)O-water using compartment and noncompartment analysis. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] Robert B Livingston,et al. Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[14] Zheng Fu,et al. Imaging of proliferation with 18F-FLT PET/CT versus 18F-FDG PET/CT in non-small-cell lung cancer , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[15] S. Larson. Positron Emission Tomography-Based Molecular Imaging in Human Cancer , 2004, Clinical Cancer Research.
[16] K J Kearfott,et al. Feasibility of simultaneous and sequentially administered dual tracer protocols for measurement of regional cerebral haematocrit using positron emission tomography. , 1990, Physics in medicine and biology.
[17] H. Schirrmeister,et al. [18F] 3-deoxy-3'-fluorothymidine positron emission tomography: alternative or diagnostic adjunct to 2-[18f]-fluoro-2-deoxy-D-glucose positron emission tomography in the workup of suspicious central focal lesions? , 2004, The Journal of thoracic and cardiovascular surgery.
[18] Hinako Toyama,et al. Simultaneous quantification of two brain functions with dual tracer injection in PET dynamic study , 2004 .
[19] H. Friess,et al. Comparison of 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography (FLT PET) and FDG PET/CT for the detection and characterization of pancreatic tumours , 2012, European Journal of Nuclear Medicine and Molecular Imaging.
[20] J Nucl Med , 2010 .
[21] Huafeng Liu,et al. Dynamic Dual-Tracer PET Reconstruction , 2009, IPMI.
[22] Luc Thiberville,et al. Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[23] A. Thiel,et al. 11C-methionine PET for differential diagnosis of low-grade gliomas , 1998, Neurology.
[24] Andrew J. Reader,et al. Simultaneous water activation and glucose metabolic rate imaging with PET , 2011, 2011 IEEE Nuclear Science Symposium Conference Record.
[25] M. Spieth,et al. A tabulated summary of the FDG PET literature. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[26] D. Mankoff,et al. Characterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors. , 2000, Neoplasia.
[27] Robert B Livingston,et al. Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[28] Takuya Hayashi,et al. Influence of residual oxygen-15-labeled carbon monoxide radioactivity on cerebral blood flow and oxygen extraction fraction in a dual-tracer autoradiographic method , 2009, Annals of nuclear medicine.
[29] M E Phelps,et al. An investigation of a double-tracer technique for positron computerized tomography. , 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[30] R. Boellaard,et al. Early prediction of nonprogression in advanced non-small-cell lung cancer treated with erlotinib by using [(18)F]fluorodeoxyglucose and [(18)F]fluorothymidine positron emission tomography. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] Tomio Inoue,et al. A shifting landseape: What will be next FDG in PET oncology? , 2002, Annals of nuclear medicine.
[32] B. Christian,et al. A comparative study on the uptake and incorporation of radiolabeled methionine, choline and fluorodeoxyglucose in human astrocytoma. , 2002, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.
[33] Bastien Guerin,et al. Simultaneous Dual Tracer PET Using Generalized Factor Analysis of Dynamic Sequences , 2006 .
[34] J. Konishi,et al. Double-injection FDG method to measure cerebral glucose metabolism twice in a single procedure , 2001, Annals of nuclear medicine.
[35] D E Kuhl,et al. Dual-[11C]Tracer Single-Acquisition Positron Emission Tomography Studies , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[36] R. Boellaard,et al. Quantitative Analysis of Response to Treatment with Erlotinib in Advanced Non–Small Cell Lung Cancer Using 18F-FDG and 3′-Deoxy-3′-18F-Fluorothymidine PET , 2011, The Journal of Nuclear Medicine.
[37] Hiroshi Watabe,et al. Separation of input function for rapid measurement of quantitative CMRO2 and CBF in a single PET scan with a dual tracer administration method , 2007, Physics in medicine and biology.
[38] Robert A Koeppe,et al. Signal Separation and Parameter Estimation in Noninvasive Dual-Tracer PET Scans using Reference-Region Approaches , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[39] Y. Nishiyama,et al. Comparison of FLT-PET and FDG-PET for Visualization of Head and Neck Squamous Cell Cancers , 2011, Molecular Imaging and Biology.
[40] R. Moore,et al. Measurement of PDT-induced hypoxia in Dunning prostate tumors by iodine-123-iodoazomycin arabinoside. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[41] M. Graham. Combined 18F-FDG-FDOPA tumor imaging for assessing response to therapy. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[42] Robert A. Koeppe,et al. Temporally Overlapping Dual-Tracer PET Studies , 1998 .
[43] P. Price,et al. Clinical measurement of blood flow in tumours using positron emission tomography: a review. , 2002, Nuclear medicine communications.
[44] R. Frackowiak,et al. Quantitative Measurement of Regional Cerebral Blood Flow and Oxygen Metabolism in Man Using 15O and Positron Emission Tomography: Theory, Procedure, and Normal Values , 1980, Journal of computer assisted tomography.
[45] A. Shields,et al. PET imaging with 18F-FLT and thymidine analogs: promise and pitfalls. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[46] David J. Yang,et al. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[47] L. Thiberville,et al. (FLT), and hypoxia with 18 fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): A pilot study , 2011 .
[48] J. Ballinger,et al. Imaging hypoxia in tumors. , 2001, Seminars in nuclear medicine.
[49] F. O’Sullivan,et al. Hypoxia and Glucose Metabolism in Malignant Tumors , 2004, Clinical Cancer Research.
[50] K. Herholz,et al. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. , 1999, European journal of cancer.
[51] D. Pareto,et al. Simultaneous Dual-tracer PET Imaging of the Rat Brain and its Application in the Study of Cerebral Ischemia , 2011, Molecular Imaging and Biology.
[52] D.J. Kadrmas,et al. Feasibility of rapid multitracer PET tumor imaging , 2004, IEEE Transactions on Nuclear Science.
[53] A. Reader,et al. Imaging apoptosis in vivo using 124I-annexin V and PET. , 2005, Nuclear medicine and biology.
[54] R. Langer,et al. Molecular Imaging of Proliferation and Glucose Utilization: Utility for Monitoring Response and Prognosis after Neoadjuvant Therapy in Locally Advanced Gastric Cancer , 2011, Annals of Surgical Oncology.
[55] J. Eary,et al. Evaluation of 18F-annexin V as a PET imaging agent in an animal model of apoptosis. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[56] Mark Muzi,et al. 18F-FDG kinetics in locally advanced breast cancer: correlation with tumor blood flow and changes in response to neoadjuvant chemotherapy. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[57] A Celler,et al. Dual-isotope PET using positron-gamma emitters , 2011, Physics in medicine and biology.
[58] Jiahe Tian,et al. Can multimodality imaging using 18F-FDG/18F-FLT PET/CT benefit the diagnosis and management of patients with pulmonary lesions? , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[59] M. Phelps,et al. Quantitating tumor glucose metabolism with FDG and PET. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[60] Dan J Kadrmas,et al. Single-scan dual-tracer FLT+FDG PET tumor characterization , 2013, Physics in medicine and biology.
[61] K Wienhard,et al. F-Dopa as an amino acid tracer to detect brain tumors. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[62] R. Wahl,et al. FDG metabolism and uptake versus blood flow in women with untreated primary breast cancers , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[63] Michael J. Morris,et al. 11C-acetate PET imaging in prostate cancer , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[64] M J Welch,et al. Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[65] A. Gjedde,et al. Quantitative functional brain imaging with positron emission tomography , 1998 .
[66] D. Kadrmas,et al. Rapid Multi-Tracer PET Tumor Imaging With $^{18}{\hbox {F-FDG}}$ and Secondary Shorter-Lived Tracers , 2009, IEEE Transactions on Nuclear Science.
[67] Tove Grönroos,et al. Quantifying tumour hypoxia with fluorine-18 fluoroerythronitroimidazole ([18F]FETNIM) and PET using the tumour to plasma ratio , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[68] Scott McJames,et al. Evaluation of rapid dual-tracer 62Cu-PTSM + 62Cu-ATSM PET in dogs with spontaneously occurring tumors , 2008, Physics in medicine and biology.
[69] M. Welch,et al. PET imaging of hypoxia. , 2001, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.
[70] A. Lammertsma,et al. Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-d-glucose and positron emission tomography: an overview of different analytical methods , 2000, European Journal of Nuclear Medicine.
[71] V. Oikonen,et al. Imaging of blood flow and hypoxia in head and neck cancer: initial evaluation with [(15)O]H(2)O and [(18)F]fluoroerythronitroimidazole PET. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[72] Otto Muzik,et al. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography , 1998, Nature Medicine.
[73] Y. Nishiyama,et al. Comparison of (18)F-FLT PET and (18)F-FDG PET for preoperative staging in non-small cell lung cancer. , 2008, European journal of nuclear medicine and molecular imaging.
[74] Manjit,et al. Neurology , 1912, NeuroImage.
[75] H. Fukuda,et al. Comparison of the distribution of fluorine-18 fluoromisonidazole, deoxyglucose and methionine in tumour tissue , 1999, European Journal of Nuclear Medicine.
[76] E. Pauwels,et al. Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose in oncology. Part IIIa: Therapy response monitoring in breast cancer, lymphoma and gliomas. , 2001, Journal of cancer research and clinical oncology.
[77] Chi-Lai Ho,et al. 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[78] H. Minn,et al. Pharmacokinetics of [18F]FETNIM: A Potential Hypoxia Marker for PET , 2001 .
[79] E. Nitzsche,et al. Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors. , 2001, Radiology.
[80] A. D. Roberts,et al. PET Measurement of rCBF in the presence of a neurochemical tracer , 2004, Journal of Neuroscience Methods.
[81] K. Någren,et al. Comparative double-tracer whole-body autoradiography: uptake of 11C-, 18F- and 3H-labeled compounds in rat tumors. , 1988, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.
[82] E. Pauwels,et al. Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose in oncology. Part IIIb: Therapy response monitoring in colorectal and lung tumours, head and neck cancer, hepatocellular carcinoma and sarcoma. , 2001, Journal of cancer research and clinical oncology.
[83] D J Kadrmas,et al. Rapid dual-tracer PTSM+ATSM PET imaging of tumour blood flow and hypoxia: a simulation study , 2006, Physics in medicine and biology.
[84] W Vaalburg,et al. Radiolabeled amino acids: basic aspects and clinical applications in oncology. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[85] Koen Van Laere,et al. Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[86] K. Leenders,et al. Alteration of blood-brain barrier in human brain tumors: comparison of [18F]fluorodeoxyglucose, [11C]methionine and rubidium-82 using PET , 1995, Journal of the Neurological Sciences.
[87] D. Kadrmas,et al. Rapid Multi-Tracer PET Tumor Imaging With F-FDG and Secondary Shorter-Lived Tracers. , 2009, IEEE transactions on nuclear science.
[88] M. Parliament,et al. Imaging tumor hypoxia and tumor perfusion. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[89] M. Knopp,et al. Special techniques for imaging blood flow to tumors. , 2002, Cancer journal.
[90] M. Mintun,et al. Breast cancer: PET imaging of estrogen receptors. , 1988, Radiology.
[91] Karl Herholz,et al. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[92] Janet F. Eary,et al. Positron emission tomography: imaging tumor response , 2000, European Journal of Nuclear Medicine.
[93] Hiroshi Watabe,et al. Rapid Quantitative Measurement of CMRO2 and CBF by Dual Administration of 15O-Labeled Oxygen and Water During a Single PET Scan—a Validation Study and Error Analysis in Anesthetized Monkeys , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[94] Jiahe Tian,et al. A Multicenter Clinical Trial on the Diagnostic Value of Dual-Tracer PET/CT in Pulmonary Lesions Using 3′-Deoxy-3′-18F-Fluorothymidine and 18F-FDG , 2008, Journal of Nuclear Medicine.
[95] R. Boellaard,et al. Predictive value of early and late residual 18F-fluorodeoxyglucose and 18F-fluorothymidine uptake using different SUV measurements in patients with non-small-cell lung cancer treated with erlotinib , 2012, European Journal of Nuclear Medicine and Molecular Imaging.